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Abstract
Biofuels derived from lignocellulosic biomass offer promising alternative renewable energy sources for transportation fuels.
Significant effort has been made to engineer Saccharomyces cerevisiae to efficiently ferment pentose sugars such as D-
xylose and L-arabinose into biofuels such as ethanol through heterologous expression of the fungal D-xylose and L-
arabinose pathways. However, one of the major bottlenecks in these fungal pathways is that the cofactors are not balanced,
which contributes to inefficient utilization of pentose sugars. We utilized a genome-scale model of S. cerevisiae to predict
the maximal achievable growth rate for cofactor balanced and imbalanced D-xylose and L-arabinose utilization pathways.
Dynamic flux balance analysis (DFBA) was used to simulate batch fermentation of glucose, D-xylose, and L-arabinose. The
dynamic models and experimental results are in good agreement for the wild type and for the engineered D-xylose
utilization pathway. Cofactor balancing the engineered D-xylose and L-arabinose utilization pathways simulated an increase
in ethanol batch production of 24.7% while simultaneously reducing the predicted substrate utilization time by 70%.
Furthermore, the effects of cofactor balancing the engineered pentose utilization pathways were evaluated throughout the
genome-scale metabolic network. This work not only provides new insights to the global network effects of cofactor
balancing but also provides useful guidelines for engineering a recombinant yeast strain with cofactor balanced engineered
pathways that efficiently co-utilizes pentose and hexose sugars for biofuels production. Experimental switching of cofactor
usage in enzymes has been demonstrated, but is a time-consuming effort. Therefore, systems biology models that can
predict the likely outcome of such strain engineering efforts are highly useful for motivating which efforts are likely to be
worth the significant time investment.
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Introduction
Reconstruction and simulation of genome-scale metabolic
networks provides a powerful approach to guide metabolic
engineering efforts [1,2,3]. Such model guided metabolic engi-
neering approaches have helped to generate rationally modified
strains with improved biological functions [4,5,6,7]. In this regard,
a genome-scale model (GEM) is highly useful to guide strain design
for improved production of chemicals and pharmaceuticals by
microorganisms as cell factories. Metabolic GEMs have been used
in industrial biotechnology for the production of chemicals,
biopolymers, and biofuels, as well as for bioremediation [8,9].
For example, the metabolic GEM for Lactococcus lactis was used to
enhance production of diacetyl, a flavoring compound found in
dairy products [10]. Moreover, the GEM of Pseudomonas putida was
used to improve the production of poly-3-hydroxyalkanoates
(PHA), which are biodegradable polyesters synthesized to replace
petrochemical based plastics [11]. Metabolic GEMs can also be
used to guide strain design for improved biofuel production by
microorganisms [9,12]. The scope of applying GEMs to strain
design continues to increase, aided by improvements in automated
reconstruction of metabolic [13] and integrated regulatory-
metabolic networks [14].
Increases in fuel prices coupled with concerns about global
warming and energy security, have rekindled interest in producing
ethanol and other biofuels from lignocellulosic raw materials such
as agriculture and forestry waste [15,16]. Pretreatment of
lignocellulose by chemical or enzymatic methods yields a mixture
of hexoses (primarily glucose and mannose) and pentose (primarily
D-xylose and L-arabinose, though L-arabinose is typically less
abundant than D-xylose) [17]. The fermentation of almost all the
available hexose and pentose sugars to biofuels is vital to the
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yield and minimize the costs associated with waste disposal [18].
The yeast S. cerevisiae is often chosen for ethanol production
because of its high inhibitor tolerance and its ability to grow at low
pH to avoid bacterial contamination [19,20]. Although well suited
for fermentation, S. cerevisiae has the substantial drawback that it
cannot fully utilize the substrates available from breakdown of
plant biomass. That is, wild type S. cerevisiae can metabolize the
hexose sugars, but not the pentose sugars. To overcome this
problem, D-xylose and L-arabinose utilization pathways have
been incorporated into the host microorganism. For example, S.
cerevisiae was engineered to utilize D-xylose using both fungal and
bacterial D-xylose utilization pathways [15,16,17,19]. In the
bacterial D-xylose utilization pathway, xylose isomerase is used
to convert D-xylose to D-xylulose, whereas xylulose kinase is
responsible for phosphorylation of D-xylulose to xylulose-5-
phosphate [21]. In the fungal D-xylose utilization pathway, D-
xylose is converted into D-xylulose by sequential action of two
enzymes as found in the D-xylose fermenting fungus Pichia stipitis
[21]. Xylose reductase (XR) catalyzes the conversion of D-xylose
to xylitol and then xylitol is oxidized by xylitol dehydrogenase
(XDH) to D-xylulose. The fungal D-xylose utilization pathway was
considered to be advantageous for bioethanol production due to its
high ethanol productivity compared to the bacterial D-xylose
utilization pathway [21].
Similarly, S. cerevisiae was engineered to utilize L-arabinose using
the fungal reduction/oxidation-based and bacterial isomerization-
based pathways. In the bacterial pathway, enzymes L-arabinose
isomerase (AI), L-ribulokinase (RK), and L-ribulose-5-P 4-
epimerase (R5PE) are responsible for conversion from L-arabinose
to L-ribulose, L-ribulose-5-P, and finally D-xylulose-5-P, respec-
tively [22]. In the fungal pathway, aldose reductase catalyzes the
conversion of L-arabinose to L-arabinitol, which is converted into
L-xylulose by L-arabinitol dehydrogenase (LAD). Finally, L-
xylulose is reduced to xylitol by L-xylulose reductase (LXR)
[23]. Thus both the D-xylose and L-arabinose pathways converge
at xylitol. Low activity of the bacterial L-arabinose pathway and
inefficient production of ethanol are the main reasons for using the
fungal L-arabinose utilization pathway in S. cerevisiae [24].
Previous studies have shown that accumulation of xylitol is
ultimately responsible for inefficient production of ethanol in
engineered S. cerevisiae strains containing the fungal pentose
utilization pathways [25]. One possible explanation for the
inefficient ethanol production is cofactor imbalance in the
introduced pathways [26], as the cofactor specificity of the
corresponding enzymes is different, with XR preferring NADPH
and XDH preferring NAD
+. Similarly, the cofactor specificity for
L-arabinitol and L-xylulose reductase are NADH and NADPH,
respectively. Thus, the operation of these pathways results in a
cofactor imbalance that places a demand on the rest of the
network to rebalance these cofactor pools. In order to eliminate
this cofactor imbalance within the engineered pathways, protein
engineering techniques are used to change the cofactor specificity
of XDH and LAD to NADP
+. This change will have the effect of
making the pathways redox neutral, meaning that they will not
cause an imbalance in cofactor utilization that would then need to
be compensated for elsewhere in the network. Aerobically NADP
+
dependent malic enzymes were used to increase the cystolic or
mitochondrial level of NADPH in S. cerevisiae [27].
We used a genome-scale constraint-based metabolic model to
study for the first time the effects on the global network that result
from cofactor balancing associated with the engineered fungal D-
xylose and L-arabinose utilization pathways. It was found that
cofactor balancing increased predicted pentose sugar utilization
efficiency while retaining the flexibility and flux correlation
structure of the wild type strain. In addition, the genome-scale
model predicts quantitatively an increase in ethanol production of
24.7% that would result from cofactor balancing the introduced
pentose utilization pathways – providing strong motivation for the
initiation of a laborious and time-consuming enzyme engineering
project to change cofactor specificity. Thus, this study provides an
example of prospective design of a labor-intensive synthetic
biology project using the tools of systems biology.
Results
(a) Modified genome-scale models of S. cerevisiae
For our simulations, we modified the most recently published
genome-scale metabolic model: S. cerevisiae iMM904 [28]. To
enable D-xylose and L-arabinose utilization, we introduced into
the model the same engineered pentose sugar utilizing pathways
that we are introducing experimentally into S. cerevisiae (Figure 1).
The resulting model consisted of 1579 reactions and 1229
metabolites. For better utilization of the substrates L-arabinose
and D-xylose, the cofactor specificity of LAD and XDH were
changed to NADP
+ as shown in Figure 1. The carbon sources used
for ethanol production were glucose, D-xylose and L-arabinose.
Here we have analyzed three models: 1) wild type (genome-scale
model containing no pentose utilizing pathways); 2) engineered
cofactor imbalanced (engineered cofactor imbalanced D-xylose and L-
arabinose utilization model); and 3) engineered cofactor balanced
(engineered cofactor balanced D-xylose and L-arabinose utiliza-
tion model). Dynamic flux balance analysis (DFBA) calculations
were done on the engineered cofactor imbalanced model and
engineered cofactor balanced model. Flux variability analysis and
sampling of the flux space were done on all the three models.
L-Arabinose and D-xylose utilization
DFBA simulation of batch fermentations for the engineered
cofactor imbalanced model was carried out using 20 g/L of
glucose in the presence of minimum oxygen for the maximization
of biomass production. Apart from glucose, D-xylose and L-
arabinose were mixed in 50 g/L and 30 g/L, respectively. The
initial concentration and uptake rates for glucose and D-xylose
were taken from reported data in literature [29]. The variation of
glucose, D-xylose, L-arabinose, ethanol, and cell biomass concen-
trations as a function of time are shown in Figure 2a. The glucose,
oxygen, D-xylose, and L-arabinose consumption rates were 6.06,
0.3, 1.2, and 1.73 mmol/gDCW/h, respectively. Oxygen-limited
fermentation of yeast on a mixture of glucose and D-xylose caused
a redox imbalance during different cofactor utilization of XR and
XDH in xylose metabolism [30]. The oxygen uptake rate was kept
very low to simulate the microaerobic environments that
maximize ethanol yield. Computationally setting the oxygen
uptake rate below 0.3 mmol/gDCW/h, we observed only D-
xylose consumption, while L-arabinose was never utilized by the
system. This observation argues for a microaerobic condition
being optimal for mixed-sugar fermentation. We have constrained
our system in such a way that utilization of D-xylose and L-
arabinose will start after complete utilization of glucose concen-
tration, to represent the experimentally observed catabolite
repression [24,29]. Glucose is fully utilized within 27 hours of
batch simulation, after which D-xylose starts to be utilized.
Utilization of D-xylose resulted in ethanol production but at the
same time we see significant production of L-arabinitol in the
model. Since the reactions in the engineered D-xylose and L-
arabinose pathways are reversible, the production of xylitol may
lead to L-arabinitol production forcing the reaction to go in the
Cofactor Balancing in Pentose Utilization Pathways
PLoS ONE | www.plosone.org 2 November 2011 | Volume 6 | Issue 11 | e27316reverse direction of the engineered L-arabinose utilization
pathway. Experimentally, pentose-fermenting S. cerevisiae strains
have shown significant amount of L-arabinitol accumulation [23].
The L-arabinitol production is maximal when D-xylose is
consumed completely. After complete consumption of D-xylose,
the system utilizes L-arabinitol for growth and not L-arabinose.
Since the NADPH load of converting L-arabinose to L-arabinitol
leads to a lower predicted growth rate, the L-arabinitol formed
during D-xylose consumption is utilized as the preferred carbon
source for cell growth. The utilization of L-arabinitol is slow and
the model simulated almost 86 hours for complete consumption.
The delay in utilization of L-arabinose after D-xylose depletion
was mainly due to cofactor imbalance created due to different
coenzyme specificity of XR and XDH. This cofactor imbalance
led to the built-up L-arabinitol being fully utilized before the L-
arabinose began to be utilized. The L-arabinose was then utilized
at a slower rate compared to D-xylose but at a similar rate to L-
arabinitol. Furthermore, L-arabinose utilization was computed to
be accompanied with small amount of acetate production. A
reduction in the consumption rate of pentose sugars from D-xylose
to L-arabinose may be related to cofactor utilization as mentioned
previously [31,32].
L-Arabinose and D-xylose utilization with a cofactor
balanced pathway
DFBA simulates extracellular L-arabinitol accumulation due to
the difference in cofactor specificity between XR with NADPH
and XDH with NAD
+. The difference in cofactor specificity leads
to additional demands on the metabolic network to maintain
intracellular redox balance. Extracellular L-Arabinitol accumula-
tion in the simulations resulted in inefficient utilization of D-
xylose/L-arabinose and decreased ethanol yield. This cofactor
imbalance issue can be addressed by two different protein
engineering strategies. One of them is to change the cofactor
Figure 1. (a) Engineered cofactor imbalanced L-arabinose and D-xylose pathways, (b) Engineered cofactor balanced L-arabinose
and D-xylose pathways. XR: Xylose reductase; LAD: L-arabitol dehydrogenase; LXR: L-xylulose reductase; XDH: xylitol dehydrogenase; XK:
xylulokinase.
doi:10.1371/journal.pone.0027316.g001
Figure 2. Dynamic flux balance analysis. Glucose, D-xylose, L-
arabinose, L-arabinitol, acetate, ethanol and biomass are shown as a
function of time for microaerobic S. cerevisiae batch growth on glucose,
D-xylose, and L-arabinose. (a) engineered cofactor imbalanced (ECI)
model. (b) engineered cofactor balanced (ECB) model.
doi:10.1371/journal.pone.0027316.g002
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+ dependent to NADP
+
dependent, whereas the other strategy involves the change of
cofactor specificity of XR and LXR from NADPH dependent to
NADH dependent. We simulated both strategies and found that
the results were equivalent. Thus, only the strategy of switching the
cofactor specificity of LAD and XDH from NAD
+ dependent to
NADP
+ to make the pathways redox neutral will be shown here
(Figure 1). Cofactor specificity of Pichia stipitis XDH (psXDH) has
been successfully changed experimentally through protein engi-
neering for efficient fermentation of D-xylose to ethanol using
recombinant S. cerevisiae [33].
Simulation of ethanol fermentation from mixed sugars was
performed with 20 g/L glucose, 50 g/L D-xylose, and 30 g/L L-
arabinose as carbon sources. The variation of glucose, D-xylose, L-
arabinose, ethanol, and cell biomass concentrations as a function
of time are shown in Figure 2b. We kept the oxygen consumption
rate to a low value of 0.01 mmol/gDCW/h. In all versions of the
model, we found lowering the oxygen uptake rate resulted in
increased ethanol production, as would be expected from
experimental behavior of S. cerevisiae. We simulated the batch
processes with both the cofactor imbalanced and cofactor
balanced pentose utilization pathways. Here we constrained our
model to utilize L-arabinose immediately after D-xylose. The
genome-scale model predicted that the strain with the engineered
cofactor balanced pathway would have significantly higher ethanol
production (46 g/L ethanol) than the strain with the cofactor
imbalanced pathway (36.9 g/L of ethanol). The engineered
cofactor balanced strain showed significant increase in biomass of
8.03 g/L compared to the cofactor imbalanced strain of 6.27 g/L
of biomass. This represents a 24.7% increase in ethanol
production from the same amount of substrate, which provides
strong motivation for experimental efforts to modify the cofactor
specificity – typically a long and laborious process. Interestingly,
extracellular L-arabinitol accumulation is not predicted when the
engineered cofactor balanced pathway is introduced, leading to
the immediate utilization of L-arabinose after complete consump-
tion of D-xylose. Furthermore, the L-arabinose consumption rate
is faster than is found with the cofactor imbalanced pathways. Also
of critical importance to overall performance, the total time
required to consume the mixed sugars glucose, D-xylose, and L-
arabinose is predicted to be just 94 hours for the strain with the
cofactor balanced pathways compared to 312 hours for the strain
with the cofactor imbalanced pathways. Thus by cofactor
balancing the metabolic network has improved ethanol production
from 36.9 g/L to 46 g/L and simultaneously reduces the
utilization time from 312 hours to 94 hours. The cofactor
balanced pathway thus has the potential to improve the
engineered S. cerevisiae strain for ethanol production.
(b) Comparison of in silico predictions and experimental
measurements
Of key importance in using the model to guide an experimental
program is to ascertain whether the predictions made from the
model are generally reliable. The genome-scale S. cerevisiae
metabolic model has been extensively validated [34,35], and we
will focus on specific predictions closest to our aims in the present
study. We also compared results with a S. cerevisiae strain [29] that
has previously been engineered to metabolize D-xylose, using a
modified genome-scale metabolic model with the engineered D-
xylose pathway introduced. Simulation of batch fermentations on
glucose and D-xylose were compared with experimental results
[29]. The consumption of glucose and D-xylose, as well as the
production of ethanol were compared over time in batch culture
and simulation (Figure 3a). Glucose is utilized first and then D-
xylose is consumed. The experimentally measured uptake rates for
glucose and D-xylose were used in batch simulation. The
concentration of glucose and D-xylose used for the culture are
20 g/L and 50 g/L, respectively. The ethanol yield was 0.29 g
ethanol (g consumed sugars)
21. Experimental batch fermentation
under the same condition as with the wild type strain of S. cerevisiae
consumed 20 and 30.4 g/L of glucose and D-xylose, respectively
and produced 16.8 g/L of ethanol [29] (Table1). These
measurements agree well with our theoretical prediction of 17.6
g/L of ethanol for the same D-xylose consumption as the
experimental measurement (Table 1). Moreover, the time taken
to consume D-xylose was more than 75 hours for both the
prediction and experimental measurement. The xylose transport
affinity in S. cerevisiae is very low compared to glucose. Previous
studies have shown that transport may control xylose utilization in
recombinant S. cerevisiae [36]. However the rate at which transport
controls the xylose uptake rate is dependent on both the substrate
concentration and the downstream pathways. The overall xylose
transport in S. cerevisiae was kinetically modeled in silico as a
function of extracellular glucose concentration [37]. The xylose
utilization can be further improved at low glucose concentration
compared to xylose concentration. One main reason for the slow
rate of D-xylose consumption is presumably that the D-xylose and
L-arabinose pathways are not redox balanced. The redox
balanced pathways in the network perform much better, since
cofactor balancing in the rest of the network remains similar to
that of the wild type strain. The cofactor balanced network model
behaved much closer to the wild type model and is further verified
using flux variability analysis and by comparing the reaction
correlation patterns.
Figure 3. Dynamic flux balance analysis. The glucose, D-xylose
and ethanol are shown as a function of time for anaerobic S. cerevisiae
batch growth on glucose and D-xylose. (a) Without cofactor balance
with engineered D-xylose pathway. (b) With cofactor balanced D-xylose
pathway.
doi:10.1371/journal.pone.0027316.g003
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+ generated during the conversion of D-xylose to xylitol
can be utilized by NAD
+ specific XDH. Recently, the batch
fermentations were done on a recombinant S. cerevisiae strain
containing the XR-XDH pathway from P. stipitis with engineered
NADH-specific XR (YPS270R) [29]. Simulations of batch
fermentation were carried out with the cofactor balanced D-
xylose pathway (Figure 3b) and compared with experimental
results. The simulation used 70 g/L sugar and produced 33 g/L
ethanol, whereas YPS270R was reported to consume 66.1 g/L
sugar and produced 25.3 g/L ethanol (Table 1). Experimental
results showed reduced xylitol accumulation which may be due to
the small difference in cofactor specificity. The ethanol production
is computed to be further improved to 33 g/L when a NADH-
specific XR is used.
(c) Range of flux variability within the genome-scale
network of S. cerevisiae
Growth rate was chosen as the objective function for the
optimization of the S. cerevisiae genome-scale metabolic network. At
optimal growth, a range of variability exists in each flux in the
network in terms of the range of flux values it can achieve at
steady-state. First, the maximum value of the biomass objective
function was calculated and then the maximum value of biomass
was used as a constraint when calculating the feasible range of
reaction fluxes by subsequent maximization and minimization of
each reaction flux. We have applied this technique, known as Flux
Variability Analysis (FVA) [38], to determine the maximum and
minimum flux values for all the reactions in a given model while
satisfying FBA mass balance conditions and all other constraints
on the system. The glucose, oxygen, D-xylose, and L-arabinose
consumption rates were 6.06, 0.3, 1.2, and 1.73 mmol/gDCW/h,
respectively for all the three models. The flux range for each
reaction at optimal growth was computed for each of the three
above-mentioned models. The reactions affected due to cofactor
balancing are selected based on range of flux values, calculated
using maximum and minimum allowed fluxes for each reaction.
The difference of flux span between engineered cofactor
imbalanced (ECI) and engineered cofactor balanced (ECB) models
is given by SC=SpanECI -SpanECB. A difference flux span or span
change (SC) was calculated between engineered cofactor imbal-
anced and engineered cofactor balanced models reactions, and are
grouped into four categories, SC . 0.5, 0.01 , SC , 0.5, 0.0 ,
SC , 0.01 and SC=0 with 4%, 42%, 19% and 35% of total
reactions respectively, in the entire metabolic network (Figure 4a,
Table S1). Almost 65% of the total reactions are affected due to
cofactor balancing of the metabolic network. A majority of the
reactions affected lie between 0.01-0.5 and only few of them
changed drastically (Figure 4b). Reactions that showed a reaction
flux span change of more than 2.8 mmol/gDCW/h were chosen
for further analysis. The ten selected reactions (PGK, GAPD,
PGM, ENO, GLYCDy, DHAK, G3PT, G3PD1ir, PYK,
PYRDC) were those whose flux variability was most changed
amongst the wild type model, engineered cofactor imbalanced
model, and engineered cofactor balanced model (Table 2). The
majority of the reactions most affected by cofactor balancing are
involved in glycolysis and phospholipid biosynthesis. The flux
variability for these selected reactions was less than 2.46 and 7.46
mmol/gDCW/h for the wild type model and the engineered
cofactor imbalanced model, respectively. Interestingly, the span of
selected reactions for the wild type model is less than the
engineered cofactor imbalanced model. The increase in variability
in reaction fluxes of the engineered cofactor imbalanced model is
associated with reduction in cell growth, which eventually affects
the overall ethanol production. The engineered cofactor balanced
model has a flux span for the selected reactions with less than or
equal to 3.38 mmol/gDCW/h and were much closer to those in
the wild type model. Thus, cofactor balancing was responsible for
the reduction in flux variability of the reactions.
(d) Sampling candidate flux distributions
The characterization of genome-scale metabolic networks based
on reaction flux distribution is an efficient way to differentiate
similar metabolic networks with perturbations to the original
system, such as the introduction of engineered metabolic
pathways. The range of metabolic fluxes that do not violate
imposed physico-chemical constraints have been characterized
through uniform random sampling of the steady-state flux space
[39,40,41]. Such analyses also enable studying the correlations
between pairs of reactions in the metabolic network to study
changes in the relationships between fluxes that are due to the
introduced pathways.
The correlation coefficient (rij) between any two fluxes (vi and vj)
in the network was evaluated using uniform random sampling of
the steady-state flux space. The glucose, oxygen, D-xylose, and L-
arabinose consumption rates were kept same for the wild type,
engineered cofactor imbalanced and cofactor balanced models.
The optimal growth rates for wild type, engineered cofactor
imbalanced model and engineered cofactor balanced model are
0.14, 0.15, 0.19 hr
21 respectively. The correlation pattern
obtained from sampling provided an efficient way to distinguish
the effects of changes to the metabolic network. Here, the
metabolic network has been changed by adding new pathways and
changing the cofactor specificity for selected reactions. Pairwise
correlation coefficients were calculated between all fluxes
(Figure 5). Two scatter plots were made to compare the engineered
cofactor imbalanced and the cofactor balanced models with the
wild type model. Scatter plot shows the points close to the diagonal
are also similar to the reaction correlation present in the wild type
model. Interestingly, the scatter plot of the engineered cofactor
imbalanced model (Figure 5a) is more scattered compared to the
engineered cofactor balanced model (Figure 5b), indicating that
cofactor balanced correlation coefficients are close to the wild type
correlation coefficients. The correlation coefficients between
selected pairs of reactions selected based on the flux variability
analysis described above are varying with different models
(Table 3). The introduction of xylose and arabinose pathways
leads to higher correlation between the reactions in the entire
metabolic network. However cofactor balancing the network has
shown significant decrease in correlation between reactions.
Therefore the reactions are much more flexible in wild type and
cofactor balanced models. The overall correlation coefficient
between wild type and engineered cofactor balanced models is as
Table 1. Comparison of model prediction with
experimentally measured ethanol production and consumed
substrates.
Substrates or Products
Cofactor
Imbalanced Cofactor Balanced
Expt (g/L)
Model
(g/L) Expt (g/L)
Model
(g/L)
Glucose Consumed 20 20 20 20
Xylose Consumed 30.4 50 46.1 50
Ethanol Produced 16.7 17.6 25.3 33
doi:10.1371/journal.pone.0027316.t001
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imbalanced models it is 0.72. Thus cofactor balancing the
engineered pathways largely restored the correlation relationships
of the wild type model based on in silico predictions. Furthermore,
uniform random samples were used to calculate the probability
distribution for fluxes in the metabolic networks of S. cerevisiae. The
probability distribution of fluxes and pairwise correlation is
calculated to show how interdependent these reactions are in the
network (Figure 6). The diagonal and off-diagonal represent the
flux distribution histograms and pairwise scatter plots, respectively
(Figure 6). The off-diagonal scatter plots represent the relation-
ships between two reaction fluxes. For example, the PDYRC and
PGK are fully correlated in the engineered cofactor imbalanced
model, whereas very low correlations were observed in the wild
type and engineered cofactor balanced models. These interde-
pendent reactions are involved in constraining the system to
operate at the suboptimal region. In Figure 6a, the red, blue and
magenta rectangular boxes were made to compare with the
patterns in the wild type model. In the engineered cofactor
imbalanced model, the probability distribution shows a decrease in
flexibility in reaction fluxes. However, the engineered cofactor
balanced model has considerably decreased the correlation among
the reaction fluxes (Figure 6c). The highlighted rectangular boxes
were marked with highly correlated reaction fluxes in the
engineered cofactor imbalanced model but less correlated in the
two other models. The shape of the probability distribution is
helpful in determining the level of independence between any two
fluxes and also identifying highly correlated reaction sets. Thus, by
introducing new D-xylose and L-arabinose pathways we see high
correlations among the reaction fluxes. The cofactor balancing of
the added pathways has diminished the correlations, and the
correlation patterns are now much more similar to those in the
wild type model.
(g) Flux coupling analysis
The functionally related coupled reaction sets are identified
using flux coupling analysis [42] on a genome-scale metabolic
network of S. cerevisiae. This procedure relies on minimization and
Figure 4. The flux span is obtained using maximum and minimum allowable flux values for all reactions. The difference of flux span
between engineered cofactor imbalanced (ECI) and engineered cofactor balanced (ECB) models is given by SC=SpanECI -SpanECB. The relative change
in flux span between ECI and ECB models are (a) grouped into SC . 0.5, 0.01 , SC , 0.5, 0.0 , SC , 0.01 and SC=0 with 4%, 42%, 19% and 35% of
total reactions respectively, in the entire metabolic network, and (b) plotted as histogram with span change on x-axis and number of reactions on the
y-axis.
doi:10.1371/journal.pone.0027316.g004
Table 2. The minimum and maximum allowable flux values for each reaction in the wild type, engineered cofactor imbalanced,
and engineered cofactor balanced models were obtained using Flux Variability Analysis (FVA).
Reaction Wild type model Engineered cofactor imbalanced model Engineered cofactor balanced model
Min Flux* Max Flux Span Min Flux Max Flux Span Min Flux Max Flux Span
PGK -11.40 -10.14 1.26 -16.21 -10.43 5.78 -16.00 -14.27 1.73
GAPD 10.14 11.40 1.26 10.43 16.21 5.78 14.27 16.00 1.73
PGM -11.40 -10.07 1.33 -16.21 -10.34 5.86 -16.00 -14.17 1.83
ENO 10.07 11.40 1.33 10.35 16.21 5.86 14.17 16.00 1.83
GLYCDy 0.00 1.86 1.86 0.00 5.64 5.64 0.00 2.76 2.76
DHAK 0.00 1.86 1.86 0.00 5.64 5.64 0.00 2.76 2.76
G3PT 0.00 1.86 1.86 0.00 5.64 5.64 0.00 2.76 2.76
G3PD1ir 0.00 2.41 2.41 0.00 6.19 6.19 0.00 3.33 3.33
PYK 10.01 12.46 2.45 10.28 16.79 6.51 14.08 17.54 3.46
PYRDC 7.69 10.89 3.2 8.14 15.6 7.46 10.64 15.26 4.62
*mmol/gDCW/h.
doi:10.1371/journal.pone.0027316.t002
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between any two reactions within the network obeying mass
balance and boundary constraints. The metabolic reaction pairs
can be categorized into the following three groups: i) fully coupled:
the activity of one reaction fixes the activity for other reaction and
vice versa, ii) directionally coupled: the activity of one reaction implies
the activity of the other but not necessarily the reverse. iii) partially
coupled: the activity of one reaction implies the activity of the other
and vice versa, iv) uncoupled: the activity of one reaction does not
implies the activity for other reaction and vice versa. These
reactions can have any flux ratio and can operate independently.
To measure and compare the extent of coupling of reactions
within the metabolic network the upper and lower limit of the flux
ratios, Rmax = max(n1/n2)&R min = min(n1/n2) were calculated
(Table S2). In most of the reaction sets the partially, directionally
and fully coupled reaction pairs have not changed their coupling
state in wild type, engineered cofactor imbalanced and cofactor
balanced (ECB) models. However the magnitude of the flux ratios
Rmax and Rmin showed a significant change for the three models.
Interestingly the flux ratios for fully coupled reaction pairs PGM-
DHAK, PGM-ENO, PGM-G3PT, PGM-GLYCDy, PGM-PGK
and PGM-PYK are exactly the same for the wild type and cofactor
balanced models. Moreover the flux ratios for partially/direction-
ally coupled reaction pairs PYK-DHAK, PYK-ENO, PYK-
G3PT, PYK-GAPD, PYK-GLYCDy, PYK-PGK, PYK-PGM,
PYK-PYRDC are similar in magnitudes for wild type and cofactor
balanced models, whereas the same flux ratios for engineered
cofactor imbalanced model are not matching with other two
models. Therefore the flux ratios are shifted with the introduction
of new D-xylose and L-arabinose pathways. The cofactor
balancing of the added pathways have shown a shift in flux ratios
and are much more similar to those in the wild type model.
Discussion
Computer simulations of GEMs allow the prediction of system
behaviors in response to various conditions and can help in strain
design for improved biochemical production. We have used a
GEM of S. cerevisiae to study for the first time the effects on the
global network that result from cofactor balancing engineered
pathways. In particular, here we focused on the introduction of
engineered fungal D-xylose and L-arabinose utilization pathways.
The difference in cofactor preference in engineered pathways
leads to intracellular redox imbalance. Our studies indicate that
cofactor balanced pentose utilization pathways will substantially
increase ethanol production. We also observed efficient utilization
of the pentose sugars by making the pathways redox balanced –
thus reducing the burden placed on the rest of the metabolic
network to compensate for the introduction of cofactor imbal-
anced pathways.
To build a GEM of S. cerevisiae that is capable of utilizing
pentose sugars, the L-arabinose and D-xylose utilization pathways
were introduced into a recently updated genome-scale metabolic
model for S. cerevisiae (iMM904). The different cofactor specificity,
NAD
+ for LAD and XDH, NADPH for XR and LXR, in
engineered D-xylose and L-arabinose utilization pathways has
contributed to intercellular redox imbalance, which results in
reduced pentose sugar consumption rates and ethanol productivity
– which the model predicts as a consequence of the demands
placed on the metabolic network to re-balance these co-factors. To
address the cofactor imbalance issue, the cofactor specificity was
changed computationally from NAD
+ to NADP
+ for two enzymes
in the D-xylose and L-arabinose utilization pathway including
LAD and XDH. The GEM predicts that engineering cofactor
balanced pathways will greatly enhance utilization of pentose
sugars and increase ethanol production. To validate the model
predictions, the computational data were compared with reported
experimental data. The experimental ethanol production is 25.3
g/L with 66.1 g/L sugar consumption, while our DFBA
calculations have shown 33 g/L of ethanol with 70 g/L of sugar
consumption, indicating a very good agreement between model
predictions and experimental data.
Based on this revised GEM, flux variability analysis was carried
out to further investigate the variation of reaction fluxes in the
entire metabolic network. The increase in flexibility of the reaction
fluxes resulted in increases in the flux range of the engineered
cofactor imbalanced model. Cofactor balancing the engineered
pathways restored network flexibility to a state that was very
similar to that of the wild type strain. Furthermore, uniform
random sampling was carried out to calculate the probability
distribution for fluxes through all reactions. Variations in
correlation patterns among the reactions were observed with the
addition of the engineered cofactor imbalanced and engineered
cofactor balanced pathways. The added D-xylose and L-arabinose
pathways have increased the correlation among the reactions of
the entire metabolic network. Furthermore, pairwise correlation
coefficients were calculated for fluxes through all reactions of wild
type, engineered cofactor imbalanced, and engineered cofactor
balanced models. The wild type network correlation pattern was
lost when D-xylose and L-arabinose pathways were added to the
cell. Thus, by adding new pathways we have seen an increase in
solution space as evident from flux variability analysis. Sampling of
allowed flux space has shown an increase in correlations among
the reactions. The reactions are interdependent with each other
Figure 5. Scatter plots of pairwise correlation coefficients of all
fluxes in the metabolic network. (a) Between the wild type (WT)
model and the engineered cofactor imbalanced (ECI) model. (b)
Between the wild type model and the engineered cofactor balanced
(ECB) model.
doi:10.1371/journal.pone.0027316.g005
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correlation map. Thus, increased correlation patterns in the
engineered cofactor imbalanced model are responsible for the
increase in rigidity of the reaction network compared to the wild
type network. The addition of new pathways to the cell affected
the solution space of the network and also the reaction correlation
patterns. The range of possible metabolic network states of the
model was much more similar to the wildtype when cofactor
balancing was performed on the engineered pathways, suggesting
that native regulation in the cell would be much more likely to
respond well to the additional carbon flux from the pentoses.
Taken together, cofactor balancing increased pentose sugar
utilization efficiency while retaining the flexibility and flux
correlation structure of the wild type strain. Moreover, model
guided cofactor balancing has emerged to help the metabolic
engineering of microorganisms to fuels production.
We used a modified genome-scale metabolic model of S.
cerevisiae to investigate the global effect of cofactor imbalance in
engineered pentose sugar utilization pathways. The insights gained
from the computational studies will enable the strain design for
improved ethanol production in a rational and systematic way.
This approach of cellular design promises solutions to some of
today’s most difficult problems in metabolic engineering of
microbes and opens up an alternative perspective to analyze
biological systems. Our future goals include the experimental
implementation of the strain design proposed herein and the
continued development of strategies for model guided biofuel
production.
Table 3. Correlation coefficients for reaction pairs were obtained for simulated wild type, engineered cofactor imbalanced and
engineered cofactor balanced models.
Reactions Reactions Wild type model
Engineered cofactor
imbalanced model
Engineered cofactor balanced
model
PGK PYRDC -0.50 -0.93 -0.32
PGK GLYCDy -0.07 -0.53 -0.13
PGK G3PT -0.06 -0.53 -0.12
PGK G3PD1ir -0.01 -0.39 -0.09
PGK ENO -0.92 -1.00 -0.92
PGK DHAK -0.07 -0.53 -0.13
PGK PYK -0.85 -0.99 -0.87
PGM PYRDC -0.45 -0.93 -0.34
PGM GLYCDy -0.09 -0.53 -0.06
PGM G3PT -0.08 -0.53 -0.05
PGM G3PD1ir -0.01 -0.39 -0.03
PGM DHAK -0.09 -0.53 -0.06
PYRDC GAPD 0.50 0.93 0.32
PYRDC GLYCDy 0.04 0.51 0.22
PYRDC G3PT 0.04 0.51 0.22
PYRDC G3PD1ir -0.05 0.35 0.17
PYRDC ENO 0.45 0.93 0.34
PYRDC DHAK 0.04 0.51 0.22
PYRDC PYK 0.43 0.93 0.31
GAPD GLYCDy 0.07 0.53 0.13
GAPD G3PT 0.06 0.53 0.12
GAPD G3PD1ir 0.01 0.39 0.09
GAPD DHAK 0.07 0.53 0.13
GLYCDy G3PD1ir 0.89 0.47 0.89
GLYCDy ENO 0.09 0.53 0.06
GLYCDy PYK 0.13 0.53 0.06
G3PT G3PD1ir 0.89 0.46 0.89
G3PT ENO 0.08 0.53 0.05
G3PT PYK 0.12 0.52 0.06
G3PD1ir ENO 0.01 0.39 0.03
G3PD1ir DHAK 0.89 0.47 0.89
G3PD1ir PYK 0.08 0.39 0.03
ENO DHAK 0.09 0.53 0.06
DHAK PYK 0.13 0.53 0.06
Engineered cofactor imbalanced model has shown higher correlation coefficient between reaction pairs compared to wild type and cofactor balanced models.
doi:10.1371/journal.pone.0027316.t003
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All studies described below were done using the Constraint-
Based Reconstruction and Analysis (COBRA) Matlab Toolbox
[43]. Functions that were extensively used in our analysis (e.g.
dynamic flux balance analysis, flux variability analysis, and flux
correlations using sampling) were run in the Matlab environment.
(a) Flux balance analysis (FBA)
We used the publicly available genome-scale metabolic network
S. cerevisiae iMM904 [28], with 1577 reactions and 1228
metabolites, as the base model for FBA analysis. FBA was carried
out on this model using the biomass as the objective function. The
LP problem that is solved is summarized below
maxcTv
subjecttoSij:vj~0
vmin
j ƒvjƒvmax
j
where c is the objective function vector, and v
max and v
min are the
vectors containing the maximum and minimum capabilities of the
fluxes.
(b) Dynamic flux balance analysis (DFBA)
Dynamic flux balance analysis was used to simulate the batch
growth of S. cerevisiae on glucose, D-xylose and L-arabinose using the
COBRA toolbox [43]. DFBA is an approach that simulates batch
cultures by incorporating quasi-steady state flux balance calcula-
tions at a series of discrete time steps [44]. The batch time was
divided into 1000 intervals, solving the optimization problem in an
iterative approach based on steady state approximation. At each
step, linear optimization was done to predict growth, nutrient
uptake, and by-product secretion rates. Furthermore, the concen-
trationwasused tocalculatethemaximumuptakeratesofsubstrates
for the next time step. The concentrations for the next time step are
calculated from the differential equation given below [44].
dX
dt
~m:X?X(tzDt)~X(t):emDt
dS
dt
~VS ex:X?S(tzDt)~S(t){VS ex:X(t):(1{emDt)
m
dP
dt
~VP ex:X?P(tzDt)~P(t){VP ex:X(t):(1{emDt)
m
X(t), S(t), P(t) are the biomass, substrate and product
concentrations, respectively, at a given time point. VS_ex and
VP_ex are the exchange fluxes for the substrate and the product,
respectively. During each small time step, Dt, we assume that
uptake and secretion rates and m are constant. The concentration
of each external metabolite was computed at each time step,
including for glucose, D-xylose, and L-arabinose. The glucose
and D-xylose uptake rates were taken from batch experiments
[29].
(c) Flux variability analysis
Flux variability analysis was used to calculate the minimum and
maximum allowable flux values for each reaction of the genome-
scale metabolic network of S. cerevisiae. The range of fluxes is useful
for understanding the redundancies in the system. First, the
maximum value of the objective function was calculated and this
value was used to calculate the feasible range of reaction fluxes by
subsequent maximization and minimization of each reaction flux
[38]. These were calculated through a series of LP problems. The
mathematical formulations for maximization and minimization
problems are shown in case 1 and case 2, respectively.
Case1 maxvj
subjecttoSij:vj~0
cTv~Zbiomass
vmin
j ƒvjƒvmax
j
Case2 minvj
subjecttoSij:vj~0
cTv~Zbiomass
vmin
j ƒvjƒvmax
j
where Zbiomass is the value of the biomass objective function. If n is
the number of fluxes then the 2n LP problems are to be solved for
flux variability analysis. The above method was applied to
determine the maximum and minimum flux values for all the
reactions in the model while satisfying FBA mass balance
conditions and all other constraints on the system [38].
(d) Flux correlations using sampling
Flux distributions in the genome-scale model corresponding to
maximal cell growth were computed using FBA. Uniform random
sampling was done to characterize the space of all flux
distributions [39]. The genome-scale metabolic networks with
small perturbations were differentiated based on the character-
ization of the solution space using random samplers [45]. The
sampling has been done using hit and run samplers with a total of
10 million steps [41]. The correlation coefficient (rij) between any
two fluxes (vi and vj) in the network was evaluated using random
sampling of the steady-state flux space [40]. The correlations
between pairs of reactions in the metabolic network were
compared with engineered and cofactor balanced models.
(e) Flux Coupling Analysis
We have applied the previously developed Flux coupling finder
for finding coupled reactions sets in constraint-based genome-scale
metabolic models [42]. All coupled reactions are identified by
calculating the minimum and maximum flux ratio given by Rmax
(max v1/v2) and Rmin (min v1/v2) respectively between two fluxes
v1 and v2.
Figure 6. Flux distribution for S. cerevisiae obtained using artificial hit and run sampling. Individual flux distribution histograms are along
the diagonal and pairwise scatter plots are off-diagonal. The off-diagonal scatter plots show the relationships between fluxes through two reactions.
The red, blue and magenta rectangular boxes were made to compare the correlation patterns in wild type model, engineered cofactor imbalanced
model and the engineered cofactor balanced model.
doi:10.1371/journal.pone.0027316.g006
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_
1 or(minRmin~v
_
1)
subjectto Sij:v
_
j~0
v
_
2~1
v
_uptake
j ~v
uptake max
j :t
v
_
j§0
t§0
The flux ratios for every pair of fluxes are used to determine
different types of coupling shared between the two fluxes v1 and v2.
(a) If Rmin=0 and Rmax . 0, then reactions are directionally
coupled
(b) If (Rmax -R min) . 0, then reactions are partially coupled.
(c) If (Rmax -R min) = 0, then reactions are fully coupled.
The reaction pairs not coming into these three categories are
termed as uncoupled reactions.
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